AIMC Topic: Disease Progression

Clear Filters Showing 371 to 380 of 783 articles

Deep learning detection of informative features in tau PET for Alzheimer's disease classification.

BMC bioinformatics
BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia, typically characterized by memory loss followed by progressive cognitive decline and functional impairment. Many clinical trials of potential therapies for AD have failed, and ...

Assessing Glaucoma Progression Using Machine Learning Trained on Longitudinal Visual Field and Clinical Data.

Ophthalmology
PURPOSE: Rule-based approaches to determining glaucoma progression from visual fields (VFs) alone are discordant and have tradeoffs. To detect better when glaucoma progression is occurring, we used a longitudinal data set of merged VF and clinical da...

Fused Sparse Network Learning for Longitudinal Analysis of Mild Cognitive Impairment.

IEEE transactions on cybernetics
Alzheimer's disease (AD) is a neurodegenerative disease with an irreversible and progressive process. To understand the brain functions and identify the biomarkers of AD and early stages of the disease [also known as, mild cognitive impairment (MCI)]...

Prediction of disease progression in patients with COVID-19 by artificial intelligence assisted lesion quantification.

Scientific reports
To investigate the value of artificial intelligence (AI) assisted quantification on initial chest CT for prediction of disease progression and clinical outcome in patients with coronavirus disease 2019 (COVID-19). Patients with confirmed COVID-19 inf...

Transfer learning for predicting conversion from mild cognitive impairment to dementia of Alzheimer's type based on a three-dimensional convolutional neural network.

Neurobiology of aging
Dementia of Alzheimer's type (DAT) is associated with devastating and irreversible cognitive decline. Predicting which patients with mild cognitive impairment (MCI) will progress to DAT is an ongoing challenge in the field. We developed a deep learni...

End-to-End Deep Learning Model for Predicting Treatment Requirements in Neovascular AMD From Longitudinal Retinal OCT Imaging.

IEEE journal of biomedical and health informatics
Neovascular age-related macular degeneration (nAMD) is nowadays successfully treated with anti-VEGF substances, but inter-individual treatment requirements are vastly heterogeneous and currently poorly plannable resulting in suboptimal treatment freq...

Prediction of disease progression and outcomes in multiple sclerosis with machine learning.

Scientific reports
Multiple Sclerosis is a chronic inflammatory disease, affecting the Central Nervous System and leading to irreversible neurological damage, such as long term functional impairment and disability. It has no cure and the symptoms vary widely, depending...

Acute hyperglycaemia in cystic fibrosis pulmonary exacerbations.

Endocrinology, diabetes & metabolism
BACKGROUND: Hyperglycaemia may contribute to failure to recover from pulmonary exacerbations in cystic fibrosis (CF). We aimed to evaluate the prevalence and mechanism of hyperglycaemia during and post-exacerbations.

Machine learning algorithm for early detection of end-stage renal disease.

BMC nephrology
BACKGROUND: End stage renal disease (ESRD) describes the most severe stage of chronic kidney disease (CKD), when patients need dialysis or renal transplant. There is often a delay in recognizing, diagnosing, and treating the various etiologies of CKD...